Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hammer

Showing results (211-220 of 265) with videos related to

Pageof 27
Sort By:
Neuropharmacology|July 7, 2024
Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neuronsChristina Mortensen, Mikkel Thy Thomsen, Katherina C Chua, et al.
General Hospital Psychiatry|July 3, 1998
Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry settingJ J Strain, G C Smith, J S Hammer, et al.
Journal of Clinical Microbiology|September 1, 1997
Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storageM Arens, W Meyer, D Brambilla, et al.
European Journal of Endocrinology|February 9, 2007
The natural course of non-functioning pituitary macroadenomasO M Dekkers, S Hammer, R J W de Keizer, et al.
Clinical Pharmacology and Therapeutics|May 26, 2023
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human HepatocytesDitte B Iversen, Ann-Cathrine Dalgård Dunvald, Daniel M Jespersen, et al.
Nature|January 20, 2022
Global fine-scale changes in ambient NO<sub>2</sub> during COVID-19 lockdownsMatthew J Cooper, Randall V Martin, Melanie S Hammer, et al.
Archives of Toxicology|October 8, 2018
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligandConstanze Knebel, Juliane Kebben, Ivano Eberini, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1E J Wolfe, L A Cavacini, M H Samore, et al.
The New England Journal of Medicine|December 10, 1981
Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesionsF P Siegal, C Lopez, G S Hammer, et al.
Nature Communications|February 9, 2024
An integrated self-optimizing programmable chemical synthesis and reaction engineArtem I Leonov, Alexander J S Hammer, Slawomir Lach, et al.
Pageof 27

Showing results (211-220 of 265) with videos related to

Sort By:
Pageof 27
Neuropharmacology|July 7, 2024
Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neuronsChristina Mortensen, Mikkel Thy Thomsen, Katherina C Chua, et al.
General Hospital Psychiatry|July 3, 1998
Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry settingJ J Strain, G C Smith, J S Hammer, et al.
Journal of Clinical Microbiology|September 1, 1997
Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storageM Arens, W Meyer, D Brambilla, et al.
European Journal of Endocrinology|February 9, 2007
The natural course of non-functioning pituitary macroadenomasO M Dekkers, S Hammer, R J W de Keizer, et al.
Clinical Pharmacology and Therapeutics|May 26, 2023
Flucloxacillin Is a Weak Inducer of CYP3A4 in Healthy Adults and 3D Spheroid of Primary Human HepatocytesDitte B Iversen, Ann-Cathrine Dalgård Dunvald, Daniel M Jespersen, et al.
Nature|January 20, 2022
Global fine-scale changes in ambient NO<sub>2</sub> during COVID-19 lockdownsMatthew J Cooper, Randall V Martin, Melanie S Hammer, et al.
Archives of Toxicology|October 8, 2018
Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligandConstanze Knebel, Juliane Kebben, Ivano Eberini, et al.
Clinical Pharmacology and Therapeutics|June 1, 1996
Pharmacokinetics of F105, a human monoclonal antibody, in persons infected with human immunodeficiency virus type 1E J Wolfe, L A Cavacini, M H Samore, et al.
The New England Journal of Medicine|December 10, 1981
Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesionsF P Siegal, C Lopez, G S Hammer, et al.
Nature Communications|February 9, 2024
An integrated self-optimizing programmable chemical synthesis and reaction engineArtem I Leonov, Alexander J S Hammer, Slawomir Lach, et al.
Pageof 27